Prelude Capital Management, LLC Staar Surgical CO Transaction History

Prelude Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $490,816 - $776,262	6,957 New	6,957 $491,000
Q2 2020 Aug 14, 2020	SELL	$29.15 - $61.54 $7,287 - $15,385	-250 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$25.01 - $42.4 $15,856 - $26,881	-634 Reduced 71.72%	250 $8,000
Q4 2019 Feb 14, 2020	BUY	$24.55 - $38.13 $21,702 - $33,706	884 New	884 $31,000
Q2 2019 Aug 14, 2019	SELL	$23.08 - $37.01 $18,094 - $29,015	-784 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$27.81 - $40.78 $69,747 - $102,276	-2,508 Reduced 76.18%	784 $27,000
Q4 2018 Feb 14, 2019	BUY	$28.91 - $50.0 $75,628 - $130,800	2,616 Added 386.98%	3,292 $105,000
Q3 2018 Nov 14, 2018	SELL	$30.85 - $50.65 $9,995 - $16,410	-324 Reduced 32.4%	676 $32,000
Q2 2018 Aug 14, 2018	SELL	$13.95 - $32.65 $6,975 - $16,325	-500 Reduced 33.33%	1,000 $31,000
Q1 2018 May 15, 2018	SELL	$14.35 - $16.5 $1,994 - $2,293	-139 Reduced 8.48%	1,500 $22,000
Q4 2017 Feb 14, 2018	BUY	$12.45 - $17.4 $13,147 - $18,374	1,056 Added 181.13%	1,639 $25,000
Q3 2017 Nov 14, 2017	BUY	$10.25 - $12.8 $5,975 - $7,462	583	583 $7,000

245

47.2M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.12B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.